Transradial Embolization A Safer Path for Treating Uterine Fibroids in Saudi Arabia

Introduction

Safety and Success of RadialUAE

A retrospective cohort study conducted at Security Forces Hospital, Riyadh, Saudi Arabia, analyzed the safety and effectiveness of UAE performed via the radial artery on 23 women with symptomatic uterine fibroids from November 2017 to October 2019.

Key Findings:

  • Mean fibroid size reduction: 49%
  • No major complications recorded
  • Poor correlation between fibroid shrinkage and BMI, age, or number of fibroids
  • Common symptom relief: menorrhagia (70%), anemia (43%), pressure symptoms (17%)
  • Hospital stay duration: Mostly 2–4 days
  • Procedure duration: Mostly under 90 minutes

This analysis confirms the growing global interest in transradial embolization for uterine fibroid management, especially in patients refusing surgery.

Broader Medical Context and Reference

Personalized Treatment & Cultural Sensitivity

The study emphasized the importance of individualized counseling, considering cultural sensitivities and reproductive concerns, particularly in Middle Eastern populations. The non-surgical nature of UAE meets the needs of patients with medical contraindications or those who wish to avoid hysterectomy due to personal or religious reasons.

Benefits of Transradial Access:

  • Less post-procedure discomfort
  • Quicker mobilization
  • Lower infection risk
  • Greater patient satisfaction

These advantages may explain the increasing preference for this route globally.

Internal Insights & Long-Term Recommendations

Patients in the study were followed up with MRI assessments to quantify fibroid volume reduction and detect potential recurrences. While the 2-year data is promising, the researchers urge five-year longitudinal studies to validate long-term efficacy and safety.

Additionally, the authors suggest developing pre-treatment prognostic algorithms, factoring in BMI, fibroid location, patient age, and hormone levels to personalize treatment plans.

Call to Action

Disclaimer: This content is generated using AI assistance and should be reviewed for accuracy and compliance before considering this article and its contents as a reference. Any mishaps or grievances raised due to the reusing of this material will not be handled by the author of this article.